Comparison of circadian, weekly, and seasonal variations of electrical storms and single events of ventricular fibrillation in patients with Brugada syndrome

Autor: Yoshiyasu Aizawa, Seiji Takatsuki, Yoshiaki Kaneko, Takashi Noda, Yoshinori Katsumata, Takahiko Nishiyama, Takehiro Kimura, Nobuhiro Nishiyama, Kotaro Fukumoto, Shinichi Niwano, Takashi Kurita, Takeshi Mitsuhashi, Shiro Kamakura, Akihiko Shimizu, Minoru Horie, Yoshifusa Aizawa, Keiichi Fukuda

Publikováno v: International Journal of Cardiology: Heart & Vasculature, Vol 11, Iss C, Pp 104-110 (2016)

In patients with Brugada syndrome (BS), VF occurred predominantly during the nocturnal period. Some patients also developed ESs. In addition to the circadian rhythm, patients showed weekly and seasonal patterns. The patients with ESs had peak episode

Externí odkaz: https://doaj.org/article/179939cf3d3541b39f46ee4e79514e4d

A cost-utility analysis for catheter ablation of atrial fibrillation in combination with warfarin and dabigatran based on the CHADS 2 score in Japan

Autor: Keiichi Fukuda, Yoshiyasu Aizawa, Shin Kashimura, Shunya Ikeda, Takahiko Nishiyama, Seiji Takatsuki, Takehiro Kimura, Kazuaki Nakajima, Nobuhiro Nishiyama, Yoshinori Katsumata, Ataru Igarashi, Akira Kunitomi, Kotaro Fukumoto, Yoko Tanimoto

Publikováno v: Journal of Cardiology. 69:89-97

Background We aimed to clarify the cost-effectiveness of an expensive combination therapy for atrial fibrillation (AF) using both catheter ablation and dabigatran compared with warfarin at each CHADS2 score for patients in Japan. Methods A Markov mod

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::176a5bed6e41ba4ee577be1c1ed54aec
https://doi.org/10.1016/j.jjcc.2016.01.008

Comparison of circadian, weekly, and seasonal variations of electrical storms and single events of ventricular fibrillation in patients with Brugada syndrome

Autor: Takashi Kurita, Shinichi Niwano, Yoshiyasu Aizawa, Takehiro Kimura, Yoshiaki Kaneko, Takashi Noda, Takahiko Nishiyama, Minoru Horie, Akihiko Shimizu, Yoshifusa Aizawa, Takeshi Mitsuhashi, Keiichi Fukuda, Kotaro Fukumoto, Nobuhiro Nishiyama, Yoshinori Katsumata, Shiro Kamakura, Seiji Takatsuki

Publikováno v: Scipedia Open Access
Scipedia SL
International Journal of Cardiology: Heart & Vasculature, Vol 11, Iss C, Pp 104-110 (2016)
International Journal of Cardiology. Heart & Vasculature

In patients with Brugada syndrome (BS), VF occurred predominantly during the nocturnal period. Some patients also developed ESs. In addition to the circadian rhythm, patients showed weekly and seasonal patterns. The patients with ESs had peak episode

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70f55f36a26b9a63e6614563f3725fff
https://doi.org/10.1016/j.ijcha.2016.05.008

Asymptomatic Cerebral Infarction During Catheter Ablation for Atrial Fibrillation: Comparing Uninterrupted Rivaroxaban and Warfarin (ASCERTAIN)

Autor: Takehiro, Kimura, Shin, Kashimura, Takahiko, Nishiyama, Yoshinori, Katsumata, Kohei, Inagawa, Yukinori, Ikegami, Nobuhiro, Nishiyama, Kotaro, Fukumoto, Yoko, Tanimoto, Yoshiyasu, Aizawa, Kojiro, Tanimoto, Keiichi, Fukuda, Seiji, Takatsuki

Publikováno v: JACC. Clinical electrophysiology. 4(12)

This randomized study compared uninterrupted rivaroxaban therapy with warfarin therapy as prophylaxis against catheter ablation (CA)-induced asymptomatic cerebral infarction (ACI) and identified the risk factors of rivaroxaban.The reported incidence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4e49a27e7211dd7d81de54d895b659a8
https://pubmed.ncbi.nlm.nih.gov/30573126

Serum Inflammation Markers Predicting Successful Initial Catheter Ablation for Atrial Fibrillation

Autor: Nobuhiro Nishiyama, Yoshinori Katsumata, Takahiko Nishiyama, Kohei Inagawa, Kotaro Fukumoto, Keiichi Fukuda, Yoko Tanimoto, Takehiro Kimura, Seiji Takatsuki, Kojiro Tanimoto, Yoshiyasu Aizawa

Publikováno v: Heart, Lung and Circulation. 23:636-643

Background We investigated various serum inflammatory markers to predict ablation responders who have no atrial fibrillation (AF) relapse after the initial ablation. Methods Forty-four consecutive AF patients (age: 59 ± 8 years, paroxysmal: 31, CHAD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11cbb688e19f3a0ff0b0fda381267e8c
https://doi.org/10.1016/j.hlc.2014.02.003